Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 11 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Accessing a base station
DNA promoters and anthrax vaccines
Television receiver
Personalized location information for mobile devices
Auto-provisioning of network services over an Ethernet access link
Method of synchronization for low power idle
Filtering method for improving the data quality of geometric tire measurements
  Randomly Featured Patents
Fiber optic connector having hermaphroditic coupling mechanism
Interconnect circuitry, multichip module, and methods of manufacturing thereof
Method and apparatus for manufacturing a helically finned heat exchanger
Adapter for light bulbs equipped with volatile active dispenser and light emitting diodes
Method of making a dielectric chuck
Hydraulic actuation ring
Open architecture for a voice user interface
Footwear upper
Gastro-intestinal adverse effect-free composition comprising an L-carnitine replacement